Citadel Advisors’s THERATECHNOLOGIES INC COM THER Stock Holding History

Citadel Advisors’s Portfolio THER Stock Details THER Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-6,500	Closed	-$5.54K	–	15668
2023 Q2	$5.54K	Buy	6,500 +500	+8%	+$426	﹤0.01%	13492
2023 Q1	$4.88K	Buy	+6,000	New	+$4.88K	﹤0.01%	13921
2022 Q2	–	Sell	-30,000	Closed	-$74K	–	14956
2022 Q1	$74K	Sell	30,000 -11,500	-28%	-$28.4K	﹤0.01%	12541
2021 Q4	$126K	Buy	+41,500	New	+$126K	﹤0.01%	12481

Other funds holding THER

MCM

MAI Capital Management Independence, Ohio $17.7B AUM 18.87% 1-Year Est. Return

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

Citadel Advisors's THER Position: Q3 2023 in Review

Citadel Advisors sold out of THERATECHNOLOGIES INC COM (THER) in Q3 2023, closing a stake of 34,704 shares — an estimated $29.6K sold.

Citadel Advisors first reported a position in THER in Q4 2019 and held it in 9 quarters. The position peaked at $142K in Q4 2019. 2 funds tracked by Wall St. Rank hold THER as of Q3 2023.

Citadel Advisors reported no remaining THERATECHNOLOGIES INC COM position as of Q3 2023 after selling out during the quarter.
Citadel Advisors sold 34,704 THERATECHNOLOGIES INC COM shares in Q3 2023, an estimated $29.6K.
Citadel Advisors first reported a position in THERATECHNOLOGIES INC COM in Q4 2019 and held it in 9 quarters.
Citadel Advisors's THERATECHNOLOGIES INC COM position peaked at $142K in Q4 2019.
2 funds tracked by Wall St. Rank held THERATECHNOLOGIES INC COM as of Q3 2023.

Based on Citadel Advisors's 13F filing for Q3 2023, filed 14 Nov 2023.